|
YME1L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.36860025721364E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.71870345417369E-11 |
| Normal-vs-Stage2 |
6.760200E-04 |
| Normal-vs-Stage3 |
1.287820E-01 |
| Normal-vs-Stage4 |
2.561600E-01 |
| Stage1-vs-Stage2 |
6.841400E-01 |
| Stage1-vs-Stage3 |
4.243700E-02 |
| Stage1-vs-Stage4 |
1.630400E-01 |
| Stage2-vs-Stage3 |
2.432800E-01 |
| Stage2-vs-Stage4 |
2.974400E-01 |
| Stage3-vs-Stage4 |
9.955400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.84430315043028E-11 |
| Normal-vs-AfricanAmerican |
1.47569999997543E-06 |
| Normal-vs-Asian |
7.144200E-01 |
| Caucasian-vs-AfricanAmerican |
8.344000E-01 |
| Caucasian-vs-Asian |
1.682640E-01 |
| AfricanAmerican-vs-Asian |
2.116400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.19968487868982E-12 |
| Normal-vs-Female |
2.154800E-01 |
| Male-vs-Female |
1.159600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.38560000000088E-05 |
| Normal-vs-Extreme_Weight |
1.43274281327876E-12 |
| Normal-vs-Obese |
5.581000E-04 |
| Normal-vs-Extreme_Obese |
5.776800E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.305000E-01 |
| Normal_Weight-vs-Obese |
3.168400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.215800E-01 |
| Extreme_Weight-vs-Obese |
1.250040E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.440800E-01 |
| Obese-vs-Extreme_Obese |
2.153400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.278600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.49180000000404E-06 |
| Normal-vs-Age(61-80Yrs) |
5.41489075800428E-12 |
| Normal-vs-Age(81-100Yrs) |
3.19580000240904E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.722400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.458700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.875500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.664100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.139900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.172600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.79631873212338E-12 |
| Normal-VS-Type2 PRCC |
4.49190000000321E-05 |
| Normal-VS-KIRP CIMP |
2.820600E-01 |
| Normal-VS-Unclassified PRCC |
6.759700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.339000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.78632999999762E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.438200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.563300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.851800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.262330E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.98949999996589E-06 |
| Normal-vs-N1 |
1.852560E-01 |
| Normal-vs-N2 |
4.815800E-01 |
| N0-vs-N1 |
5.430200E-02 |
| N0-vs-N2 |
5.535800E-01 |
| N1-vs-N2 |
7.582000E-01 |
|
|
